Structural and mechanistic insights into disease-associated endolysosomal exonucleases PLD3 and PLD4

被引:4
|
作者
Yuan, Meng [1 ]
Peng, Linghang [2 ]
Huang, Deli [2 ,4 ,5 ]
Gavin, Amanda [2 ]
Luan, Fangkun [2 ]
Tran, Jenny [2 ]
Feng, Ziqi [1 ]
Zhu, Xueyong [1 ]
Matteson, Jeanne [1 ]
Wilson, Ian A. [1 ,3 ]
Nemazee, David [2 ]
机构
[1] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA
[3] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
[4] Zhejiang Univ, Life Sci Inst, Hangzhou 310058, Zhejiang, Peoples R China
[5] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China
关键词
DOUBLE-STRANDED DNA; PHOSPHOLIPASE-D; CRYSTAL-STRUCTURE; ACID-PHOSPHATASE; GENE; ENZYME; VARIANTS;
D O I
10.1016/j.str.2024.02.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Endolysosomal exonucleases PLD3 and PLD4 (phospholipases D3 and D4) are associated with autoinflam- matory and autoimmune diseases. We report structures of these enzymes, and the molecular basis of their catalysis. The structures reveal an intra-chain dimer topology forming a basic active site at the interface. Like other PLD superfamily members, PLD3 and PLD4 carry HxKxxxxD/E motifs and participate in phospho- diester-bond cleavage. The enzymes digest ssDNA and ssRNA in a 5 0 -to -3 0 manner and are blocked by 5 0 -phosphorylation. We captured structures in apo, intermediate, and product states and revealed a "link- and-release"two-step catalysis. We also unexpectedly demonstrated phosphatase activity via a covalent 3-phosphohistidine intermediate. PLD4 contains an extra hydrophobic clamp that stabilizes substrate and could affect oligonucleotide substrate preference and product release. Biochemical and structural analysis of disease -associated mutants of PLD3/4 demonstrated reduced enzyme activity or thermostability and the possible basis for disease association. Furthermore, these findings provide insight into therapeutic design.
引用
收藏
页码:766 / 779.e7
页数:22
相关论文
共 50 条
  • [31] Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease
    Wang, Chong
    Tan, Lan
    Wang, Hui-Fu
    Yu, Wan-Jiang
    Liu, Ying
    Jiang, Teng
    Tan, Meng-Shan
    Hao, Xiao-Ke
    Zhang, Dao-Qiang
    Yu, Jin-Tai
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 46 (02) : 491 - 495
  • [32] PLD3 in Alzheimer’s Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses
    Deng-Feng Zhang
    Yu Fan
    Dong Wang
    Rui Bi
    Chen Zhang
    Yiru Fang
    Yong-Gang Yao
    Molecular Neurobiology, 2016, 53 : 4034 - 4045
  • [33] PLD3 in Alzheimer's Disease: a Modest Effect as Revealed by Updated Association and Expression Analyses
    Zhang, Deng-Feng
    Fan, Yu
    Wang, Dong
    Bi, Rui
    Zhang, Chen
    Fang, Yiru
    Yao, Yong-Gang
    MOLECULAR NEUROBIOLOGY, 2016, 53 (06) : 4034 - 4045
  • [34] Fraternal twins at work: Structures of PLD3/4 reveal mechanism for lysosomal nucleic acid breakdown
    Daumke, Oliver
    Damme, Markus
    STRUCTURE, 2024, 32 (06)
  • [35] Phospholipase D3 (PLD3) mRNA expression is decreased in the hippocampus of Alzheimer's disease patients
    Altuna, M.
    Blanco, I.
    Sanchez-Ruiz de Gordoa, J.
    Zelaya, M.
    Roldan, M.
    Urdanoz, A.
    Larumbe Ilundain, R.
    Jerico, I.
    Erro, E.
    Echavarri, C.
    Mendioroz, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 447 - 447
  • [36] FRET Nanosensor Based on DNA Tetrahedron for Visualizing PLD3 Fluctuation in Mouse Models of Alzheimer's Disease
    Wen, Shuyan
    Ju, Zizhao
    Wang, Yiqing
    Zuo, Chuan-Tao
    Sun, Xiaotian
    Zheng, Tingting
    ACS APPLIED MATERIALS & INTERFACES, 2025, 17 (09) : 13461 - 13470
  • [37] Excess of rare coding variants in PLD3 in late- but not early-onset Alzheimer’s disease
    Eva C Schulte
    Alexander Kurz
    Panagiotis Alexopoulos
    Harald Hampel
    Annette Peters
    Christian Gieger
    Dan Rujescu
    Janine Diehl-Schmid
    Juliane Winkelmann
    Human Genome Variation, 2 (1)
  • [38] Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium Cohort
    Cacace, Rita
    Van den Bossche, Tobi
    Engelborghs, Sebastiaan
    Geerts, Nathalie
    Laureys, Annelies
    Dillen, Lubina
    Graff, Caroline
    Thonberg, Hakan
    Chiang, Huei-Hsin
    Pastor, Pau
    Ortega-Cubero, Sara
    Pastor, Maria A.
    Diehl-Schmid, Janine
    Alexopoulos, Panagiotis
    Benussi, Luisa
    Ghidoni, Roberta
    Binetti, Giuliano
    Nacmias, Benedetta
    Sorbi, Sandro
    Sanchez-Valle, Raquel
    Llado, Albert
    Gelpi, Ellen
    Almeida, Maria Rosario
    Santana, Isabel
    Tsolaki, Magda
    Koutroumani, Maria
    Clarimon, Jordi
    Lleo, Alberto
    Fortea, Juan
    de Mendonca, Alexandre
    Martins, Madalena
    Borroni, Barbara
    Padovani, Alessandro
    Matej, Radoslav
    Rohan, Zdenek
    Vandenbulcke, Mathieu
    Vandenberghe, Rik
    De Deyn, Peter P.
    Cras, Patrick
    van der Zee, Julie
    Sleegers, Kristel
    Van Broeckhoven, Christine
    HUMAN MUTATION, 2015, 36 (12) : 1226 - 1235
  • [39] Mechanistic Insights and Characterization of Sickle Cell Disease-Associated Cardiomyopathy
    Desai, Ankit A.
    Patel, Amit R.
    Ahmad, Homaa
    Groth, John V.
    Thiruvoipati, Thejasvi
    Turner, Kristen
    Yodwut, Chattanong
    Czobor, Peter
    Artz, Nicole
    Machado, Roberto F.
    Garcia, Joe G. N.
    Lang, Roberto M.
    CIRCULATION-CARDIOVASCULAR IMAGING, 2014, 7 (03) : 431 - U29
  • [40] Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variants
    Carola G. Vinuesa
    Nan Shen
    Thuvaraka Ware
    Nature Reviews Nephrology, 2023, 19 : 558 - 572